With the world digestive health market estimated at $44.4 billion in 2022 and microbiome subcategories forecast to grow at a rate of 6-10% by 2027 to 2029, formulators are increasingly looking for powerful, clinically supported probiotic ingredients. 

Morinaga BB536^® is a proprietary room-temperature and stable strain of Bifidobacterium longum commonly found in the human intestine.  It is easily one of the most researched and effective probiotic strains and is supported by over 50 published human clinical studies. 

Bifidobacterium levels decline with age, making supplementation a wise consumer choice. Clinical studies show that Morinaga BB536 supports a healthy immune system, helps with digestive regularity, supports natural detoxification, supports the balance of healthy bacteria and supports healthy cholesterol levels already in a proper range. 

Download now to learn more!